Medicine is both a science and an art.
Em outubro de 2020, o presidente dos Estados Unidos Donald Trump foi hospitalizado no Walter Reed após contrair COVID-19, tornando-se o centro de uma tensão que já consumia o mundo há meses. Sua doença — tratada com um arsenal farmacológico raramente disponível a qualquer outro paciente — levantou questões que transcendem a política: o que uma nação revela, e o que oculta, quando o corpo de seu líder se torna o campo de batalha de uma pandemia? A distância entre o que foi dito e o que foi tratado permaneceu, como tantas vezes na história, maior do que o silêncio entre as palavras.
- Trump testou positivo para COVID-19 em 1º de outubro e foi internado no Walter Reed na tarde de sexta-feira, com saturação de oxigênio caindo para 93%, sinalizando possível comprometimento pulmonar.
- A equipe médica administrou simultaneamente três tratamentos distintos — anticorpos monoclonais experimentais da Regeneron, o antiviral remdesivir e o corticosteroide dexametasona — uma combinação que desconcertou especialistas e acendeu debates sobre a real gravidade do quadro.
- Médicos de renome divergiram publicamente: enquanto Eric Topol via na abordagem os sinais clássicos da 'síndrome VIP', Gregory Poland defendia que a agressividade terapêutica poderia ser justificada pela incerteza científica do momento.
- O médico pessoal de Trump, Sean Conley, recusou-se a confirmar se havia pneumonia e usou linguagem deliberadamente vaga sobre os exames de imagem, aprofundando a desconfiança sobre o que estava sendo omitido.
- Após três noites internado, Trump retornou à Casa Branca sem ter necessitado de ventilação mecânica — mas o conjunto de intervenções recebidas sugeria uma doença mais grave do que a narrativa oficial admitia.
Donald Trump testou positivo para COVID-19 em 1º de outubro de 2020, embora a Casa Branca tenha se recusado a informar quando ocorreu seu último teste negativo. Na tarde de sexta-feira, dia 2, ele foi internado no Walter Reed, hospital militar que atende presidentes americanos, onde permaneceria por três noites.
Os sintomas iniciais incluíam febre alta, fadiga intensa, tosse persistente e congestão nasal. Mais preocupante eram os números: a saturação de oxigênio de Trump caiu para 94% na sexta-feira e para 93% no sábado — valores que sugerem envolvimento pulmonar. Ele recebeu oxigênio suplementar na Casa Branca antes da internação, e as respostas do médico Sean Conley sobre episódios posteriores foram deliberadamente evasivas.
O tratamento que se seguiu chamou atenção da comunidade médica. Ainda na Casa Branca, Trump recebeu uma dose experimental de anticorpos monoclonais da Regeneron, normalmente restrita a ensaios clínicos. Nos dias seguintes, foram adicionados remdesivir — antiviral reservado a pacientes que necessitam de suporte de oxigênio — e dexametasona, um corticosteroide indicado para casos graves, capaz de reduzir a mortalidade ao combater inflamações severas. Três medicamentos, cada um voltado a uma fase diferente da infecção, administrados ao mesmo tempo.
Eric Topol, do Scripps Research, identificou na abordagem os traços da chamada 'síndrome VIP' — o excesso terapêutico que acomete pacientes de alto perfil. Já Gregory Poland, da Mayo Clinic, argumentou que, diante de uma pandemia com dados ainda incompletos, escolhas agressivas poderiam ser razoáveis. O regime ainda incluía zinco, vitamina D, famotidina, melatonina e aspirina.
Conley recusou-se a confirmar se Trump havia desenvolvido pneumonia, descrevendo os exames de imagem com linguagem opaca. O presidente não precisou de ventilação mecânica e retornou à Casa Branca na segunda-feira, após vídeos do fim de semana mostrarem aparente recuperação. Mas a distância entre a narrativa pública e a extensão do tratamento recebido permaneceu sem resposta clara — um intervalo que, em si mesmo, dizia mais do que qualquer comunicado oficial.
Donald Trump tested positive for COVID-19 on Thursday, October 1st, according to White House spokesperson Kayleigh McEnany, though the exact date he contracted the virus remains unknown. The White House declined to disclose when his last negative test occurred. By Friday afternoon, October 2nd at 6:30 p.m. local time, he was admitted to Walter Reed, the military hospital that serves the nation's presidents. He would spend three nights there.
The illness began with recognizable symptoms: high fever, exhaustion, a persistent cough, and nasal congestion. His physician, Sean Conley, noted that Trump did not experience shortness of breath—at least not initially. But the numbers told a different story. His blood oxygen saturation, which should sit comfortably above 95 percent, dropped to 94 percent on Friday and fell further to 93 percent on Saturday. These readings suggested potential lung involvement. Trump received supplemental oxygen at the White House on Friday; whether he received it again on Saturday remained unclear, as Conley offered only evasive answers to direct questions.
What followed was a cascade of interventions that puzzled many in the medical community. On Friday, still at the White House, Trump received an 8-gram dose of an experimental monoclonal antibody treatment from Regeneron Pharmaceuticals. The drug works by deploying laboratory-produced antibodies designed to neutralize the coronavirus. Clinical trial results looked promising, but the treatment remained largely restricted to research settings—with exceptions made, apparently, for the sitting president. Over the following days, he also received remdesivir, an antiviral medication administered intravenously once daily, which attempts to block the virus from replicating. Remdesivir had been the first antiviral to receive emergency authorization against COVID-19 and is typically reserved for patients requiring oxygen support. Beginning Saturday, Trump also started dexamethasone, a corticosteroid proven to reduce mortality in severe cases by combating the dangerous inflammation that can ravage the lungs and other vital organs.
Three separate drugs, each designed for different phases of infection, administered simultaneously to a single patient. The medical establishment took notice. Eric Topol, director of the Scripps Research Translational Institute, saw in this approach the hallmark of what he called VIP syndrome—the phenomenon where a high-profile patient receives treatment divorced from evidence and is over-treated as a result. Conley himself had acknowledged they were in "uncharted territory." Yet other physicians offered a different interpretation. Gregory Poland, a professor of medicine at the Mayo Clinic, suggested that in the midst of a pandemic, doctors operating with incomplete data might reasonably make aggressive choices. "Medicine is both a science and an art," he noted.
Beyond the three major treatments, Trump's regimen expanded to include zinc, vitamin D, famotidina (typically used for heartburn), melatonin (commonly prescribed for sleep), and aspirin. The sheer pharmaceutical arsenal raised an obvious question: Was Trump sicker than his doctors were saying, or had caution tipped into excess? His public appearances offered mixed signals. Video messages released over the weekend showed him without obvious signs of distress. On Sunday, he briefly left the hospital in a motorcade to wave at supporters gathered outside, a gesture that suggested recovery was underway. His chief of staff, Mark Meadows, reported that Trump had made "incredible progress" and might return to the White House by Monday. Phone calls with various contacts continued throughout the weekend. Yet the oxygen drops, the experimental drugs, the corticosteroids—these spoke to a more serious situation than the public messaging conveyed.
When pressed about whether Trump had developed pneumonia, Conley declined to answer, saying he was "not authorized to discuss that." His description of the president's lung imaging was similarly opaque: they had made "the expected observations," he said, but nothing "clinically significant." The gap between what was being disclosed and what the treatment regimen suggested remained unresolved. Trump did not require a ventilator, a fact that stood in his favor. But the three nights at Walter Reed, the oxygen supplementation, the experimental antibodies, the antivirals, the steroids—all of it pointed to an illness serious enough to demand the full arsenal of modern medicine, deployed with the urgency and resources available only to a president.
Citações Notáveis
It is the example of VIP syndrome, in which the patient receives irrational treatment without evidence-based foundation and is over-treated.— Eric Topol, director of Scripps Research Translational Institute
His health continues to improve and he has made incredible progress.— Mark Meadows, Trump's chief of staff
A Conversa do Hearth Outra perspectiva sobre a história
Why did doctors give him three different classes of drugs at once? That seems unusual.
It does, and that's what troubled many physicians. Each drug targets a different stage of the infection—the antibodies early on, the antiviral to stop replication, the steroid to tamp down the dangerous inflammation. Giving all three simultaneously blurs the picture of how sick he actually was.
So they might have been overcautious?
That's one theory. Some doctors called it VIP syndrome—treating a high-profile patient with everything available, regardless of whether the evidence supports it. Others said that in a pandemic, with incomplete data, aggressive medicine is defensible.
What did the oxygen numbers mean?
His blood oxygen dropped to 93 and 94 percent. Normal is above 95. Those readings suggest the virus was affecting his lungs. He needed supplemental oxygen to keep those numbers up.
But he didn't need a ventilator?
No. That's significant. A ventilator would have meant severe respiratory failure. He avoided that.
Why wouldn't his doctor just say if he had pneumonia?
That's the puzzle. When asked directly, Conley said he wasn't authorized to discuss it. The evasiveness itself became part of the story—what wasn't being said mattered as much as what was.
Did he seem to recover quickly?
The public signals suggested recovery. Video messages, a Sunday drive to wave at supporters, his chief of staff saying he'd made incredible progress. But those same signals coexisted with the oxygen drops and the experimental drugs. The timeline didn't quite add up.